Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 15.30 -0.1 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.40 | 52 Week High | $12.48 | |||
| Open | $15.68 | 52 Week Low | $1.60 | |||
| Day High | $15.86 | P/E | N/A | |||
| Day Low | $15.08 | EPS | $-6.33 | |||
| Volume | 2,537,837 | |||||

